Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

ClinicalTrials.gov ID: NCT00707980

Public ClinicalTrials.gov record NCT00707980. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-Term, Open-Label, Flexible-Dose, Extension Study Evaluating the Safety and Tolerability of Lu AA21004 in Subjects With Major Depressive Disorder

Study identification

NCT ID
NCT00707980
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
836 participants

Conditions and interventions

Interventions

  • Vortioxetine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 76 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2008
Primary completion
Jun 30, 2010
Completion
Jul 31, 2010
Last update posted
Dec 12, 2013

2008 – 2010

United States locations

U.S. sites
38
U.S. states
18
U.S. cities
38
Facility City State ZIP Site status
Not listed Beverly Hills California
Not listed Irvine California
Not listed Santa Ana California
Not listed Torrance California
Not listed Upland California
Not listed Bradenton Florida
Not listed Coral Springs Florida
Not listed Fort Walton Beach Florida
Not listed Gainesville Florida
Not listed Jacksonville Florida
Not listed Maitland Florida
Not listed Orlando Florida
Not listed South Miami Florida
Not listed West Palm Beach Florida
Not listed Atlanta Georgia
Not listed Smyrna Georgia
Not listed Chicago Illinois
Not listed Libertyville Illinois
Not listed Oak Brook Illinois
Not listed Prairie Village Kansas
Not listed Owensboro Kentucky
Not listed Baltimore Maryland
Not listed Pittsfield Massachusetts
Not listed Worcester Massachusetts
Not listed Flowood Mississippi
Not listed New York New York
Not listed Olean New York
Not listed Beachwood Ohio
Not listed Toledo Ohio
Not listed Oklahoma City Oklahoma
Not listed Allenport Pennsylvania
Not listed Lancaster Pennsylvania
Not listed Memphis Tennessee
Not listed Austin Texas
Not listed San Antonio Texas
Not listed Salt Lake City Utah
Not listed Seattle Washington
Not listed Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00707980, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 12, 2013 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00707980 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →